Global Antibody Drug Conjugates Market Opportunities, Trends and Forecast by 2022- Market Research Report 2017

March 24 04:52 2017

Orbis Research
OrbisResearch.com has published new research report on “Global Antibody Drug Conjugates (ADC) Market-Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)-By Region (N. America, Europe, APAC, RoW); By Country (US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa)” to its database.

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Antibody Drug Conjugates Market on the basis of Analysis By Drug (Adcetris, Kadcyla), Pipeline Analysis (Developer, Phase, Indication, Status, Cytotoxic Payload, Linker, Target), By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, U.K., Germany, France, China, India, Japan, Singapore, Brazil and South Africa).

Browse the report: http://www.orbisresearch.com/reports/index/global-antibody-drug-conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and-forecasts-2017-2022

Over the recent years, the global antibody drug conjugates industry has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

According to Azoth Analytics research report, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 – 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Request a sample of the report: http://www.orbisresearch.com/contacts/request-sample/234660

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years

The report titled, “Global Antibody Drug Conjugates (ADC) Market – Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)”, has covered and analysed the potential of Global Antibody Drug Conjugates Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global food service equipment market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Buy the [email protected]http://www.orbisresearch.com/contact/purchase/234660

Scope of the Report
Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
Antibody Drug Conjugates Market (ADC) Market
Adcetris Market
Kadcyla Market
ADC Pipeline – By Developer, Phase, Indication and Status
ADC Pipeline – By Cytotoxic Payload, Linker and Target

Regional Markets – N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
Antibody Drug Conjugates Market (ADC) Market
Adcetris Market
Kadcyla Market
ADC Pipeline – By Developer, Phase, Indication and Status
ADC Pipeline – By Cytotoxic Payload, Linker and Target

Country Analysis – US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
Antibody Drug Conjugates Market (ADC) Market

Other Report Highlights:
Market Dynamics – Trends, Drivers, Challenges
Porter’s Five Forces Analysis
SWOT Analysis
Policy and Regulation
Company Analysis – Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon, Progenics Pharmaceuticals

Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Major Points From Table Of Contents:

Research Methodology

Executive Summary

Strategic Recommendations

Antibody Drug Conjugates Product Overview

Global Antibody Drug Conjugates Market: Growth and Forecast

Global Antibody Drug Conjugates Market: By Drug (Adcetris, Kadcyla)

Global Antibody Drug Conjugates Market: Pipeline Analysis

Global Antibody Drug Conjugates Market: Regional Analysis

Market Dynamics

Market Trends

Porter’s Five Forces Analysis – Antibody Drug Conjugates Market

SWOT Analysis – Antibody Drug Conjugates Market

Policy and Regulatory Landscape

Company Profiling

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Media Contact
Company Name: Orbis Research
Contact Person: Hector Costello
Email: Send Email
Phone: +1 (214) 884-6817
Address:4144N Central Expressway, Suite 600
City: Dallas
State: Texas
Country: United States
Website: http://www.orbisresearch.com/reports/index/global-antibody-drug-conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and-forecasts-2017-2022

  Categories: